Skip to content

13F-HR filed by Wealthfront Advisers LLC

Wealthfront Advisers LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-06, with 1,007 holding rows worth $42,596,216,296.

Accession
0002085853-25-000235
Filed
2025-11-06
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 1,007 entries on the cover page, a total value of $42,596,216,296 stated on the cover page (in dollars after the unit check, H1), rows summing to $42,596,216,296 with VALUE read as dollars as filed, 13F file number 028-19298. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
RECURSION PHARMACEUTICALS IN75629V104CL A11,586$56,540dollars as filed
CLOVER HEALTH INVESTMENTS CO18914F103COMMON STOCK15,140$46,328dollars as filed
IOVANCE BIOTHERAPEUTICS INC462260100COM15,492$33,618dollars as filed
GOPRO INC38268T103CL A13,568$28,764dollars as filed
IMMUNITYBIO INC45256X103COM11,249$27,673dollars as filed
LUMINAR TECHNOLOGIES INC550424303COM NEW CL A11,357$21,692dollars as filed
BEYOND MEAT INC08862E109COM10,533$19,907dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0002085853-25-000235this filing2025-11-06acceptance time not in the bulk data set